Literature DB >> 8116913

Estimation and model selection in constrained deconvolution.

D Verotta1.   

Abstract

We analyze in detail the estimation problem associated with the following problem. Given n noisy measurements (yi, i = 1, ..., n) of the response of a system to an input (A(t) where t indicates time), obtain an estimate of A(t) given a known K(t) (the unit impulse response function of the system) under the model: yi = integral of 0(ti) A(s)K(ti - s)ds + epsilon i where epsilon 1, ... ,epsilon n are independent identically distributed random variables with mean zero and common finite variance. In the solution to the problem, the unknown function is represented by a spline function, and the problem is recast in terms of (inequality constrained) linear regression. The main issues addressed are: (a) the comparison of different nonparametric regression methods in this context, and (b) how to do model selection, i.e., given a (finite) set of candidate spline functions, select the (possibly unique) best one using some (statistically based) selection criteria. Different spline candidate sets, and different asymptotic and resampling-based statistical selection criteria are compared by means of simulations. Due to the particular nature of the estimation problem, modifications to the criteria are suggested. Applications to simulated and real pharmacokinetics data are reported.

Mesh:

Substances:

Year:  1993        PMID: 8116913     DOI: 10.1007/bf02368641

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  11 in total

1.  Some fundamental considerations of the applications of pharmacokinetics to cancer chemotherapy.

Authors:  K B Bischoff
Journal:  Cancer Chemother Rep       Date:  1975 Jul-Aug

2.  Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures.

Authors:  V F Smolen
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

3.  A semiparametric approach to physiological flow models.

Authors:  D Verotta; L B Sheiner; W F Ebling; D R Stanski
Journal:  J Pharmacokinet Biopharm       Date:  1989-08

Review 4.  An inequality-constrained least-squares deconvolution method.

Authors:  D Verotta
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

5.  Semiparametric approach to pharmacokinetic-pharmacodynamic data.

Authors:  D Verotta; S L Beal; L B Sheiner
Journal:  Am J Physiol       Date:  1989-04

6.  Numerical deconvolution using system identification methods.

Authors:  S Vajda; K R Godfrey; P Valko
Journal:  J Pharmacokinet Biopharm       Date:  1988-02

7.  Reconstructing the rate of appearance of subcutaneous insulin by deconvolution.

Authors:  C Cobelli; A Mari; S Del Prato; S De Kreutzenberg; R Nosadini; I Jensen
Journal:  Am J Physiol       Date:  1987-11

8.  Monotone smoothing with application to dose-response curves and the assessment of synergism.

Authors:  C Kelly; J Rice
Journal:  Biometrics       Date:  1990-12       Impact factor: 2.571

9.  High-performance liquid chromatographic method for determining thiopental concentrations in twelve rat tissues: application to physiologic modeling of disposition of barbiturate.

Authors:  W F Ebling; L Mills-Williams; S R Harapat; D R Stanski
Journal:  J Chromatogr       Date:  1989-05-30

10.  Deconvolution of episodic hormone data: an analysis of the role of season on the onset of puberty in cows.

Authors:  F O'Sullivan; J O'Sullivan
Journal:  Biometrics       Date:  1988-06       Impact factor: 2.571

View more
  12 in total

1.  Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input profile.

Authors:  K Park; D Verotta; S K Gupta; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1998-08

2.  An extended point-area deconvolution approach for assessing drug input rates.

Authors:  K C Yeh; D J Holder; G A Winchell; L A Wenning; T Prueksaritanont
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

3.  Method for the deconvolution of auditory steady-state responses.

Authors:  G Sparacino; A Nale; R Santarelli; E Arslan
Journal:  Med Biol Eng Comput       Date:  2004-07       Impact factor: 2.602

4.  Volterra series in pharmacokinetics and pharmacodynamics.

Authors:  Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-10       Impact factor: 2.745

5.  A nonparametric subject-specific population method for deconvolution: I. Description, internal validation, and real data examples.

Authors:  K E Fattinger; D Verotta
Journal:  J Pharmacokinet Biopharm       Date:  1995-12

6.  Removal of catheter distortion in multiple indicator dilution studies: a deconvolution-based method and case studies on glucose blood-tissue exchange.

Authors:  G Sparacino; P Vicini; R Bonadonna; P Marraccini; M Lehtovirta; E Ferrannini; C Cobelli
Journal:  Med Biol Eng Comput       Date:  1997-07       Impact factor: 2.602

7.  Pharmacokinetic-pharmacodynamic (PK-PD) modelling in non-steady-state studies and arterio-venous drug concentration differences.

Authors:  M Gumbleton; S Oie; D Verotta
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

8.  Two constrained deconvolution methods using spline functions.

Authors:  D Verotta
Journal:  J Pharmacokinet Biopharm       Date:  1993-10

9.  Population pharmacokinetic modeling of a subcutaneous depot for GnRH antagonist degarelix.

Authors:  Christoffer W Tornøe; Henrik Agersø; Henrik A Nielsen; Henrik Madsen; E Niclas Jonsson
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

10.  The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2003-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.